Generalized anxiety and C-reactive protein levels: A prospective, longitudinal analysis

Psychological Medicine

Volumn 42, Issue 12, 2012, Pages 2641-2650

  Copeland, W E ^a   Shanahan, L ^b   Worthman, C ^c   Angold, A ^a   Costello, E J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Adolescence; C reactive protein; childhood; epidemiology; generalized anxiety disorder; inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SOMATOFORM DISORDER; STATISTICS; UNITED STATES;

ADOLESCENT; ANXIETY DISORDERS; C-REACTIVE PROTEIN; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NORTH CAROLINA; PROSPECTIVE STUDIES; SOMATOFORM DISORDERS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84868338375     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291712000554     Document Type: Article

References (59)

1. Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, Rapee RM, Ruscio AM, Stanley MA (2010). Generalized worry disorder: A review of DSM-IV generalized anxiety disorder and options for DSM-V. Depression and Anxiety 27, 134-147.
2. Angold A, Costello E (2000). The Child and Adolescent Psychiatric Assessment (CAPA). Journal of the American Academy of Child and Adolescent Psychiatry 39, 39-48. (Pubitemid 30029898)
3. Angold A, Costello EJ (1995). A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). Psychological Medicine 25, 755-762.
4. Angold A, Costello EJ, Erkanli A (1999a). Comorbidity. Journal of Child Psychology and Psychiatry 40, 57-87. (Pubitemid 29051937)
5. Angold A, Cox A, Prendergast M, Rutter M, Simonoff E, Costello EJ, Ascher BH (1999b). The Young Adult Psychiatric Assessment (YAPA). Duke University Medical Center: Durham, NC.
6. APA (1994). Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV). American Psychiatric Press, Inc.: Washington, DC.
7. Ascher BH, Farmer EMZ, Burns BJ, Angold A (1996). The Child and Adolescent Services Assessment (CASA): description and psychometrics. Journal of Emotional and Behavioral Disorders 4, 12-20.
8. Baron RM, Kenny DA (1986). The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 1173-1182.
9. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ (2012). Cumulative depression episodes predict later C-reactive protein levels: A prospective analysis. Biological Psychiatry 71, 15-21.
10. Costello EJ, Angold A, Burns B, Stangl D, Tweed D, Erkanli A, Worthman C (1996). The Great Smoky Mountains Study of Youth: goals, designs, methods, and the prevalence of DSM-III-R disorders. Archives of General Psychiatry 53, 1129-1136. (Pubitemid 26422065)
11. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 60, 837-844. (Pubitemid 36960915)
12. Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 65, 409-415.
13. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46-56. (Pubitemid 350295688)
14. DSM-5 Anxiety Disorders Work Group (2010). Proposed Revisions for Generalized Anxiety Disorder (http://www. dsm5.org/ProposedRevisions/Pages/ proposedrevision. aspx?rid=167). American Psychiatric Association: Washington, DC.
15. Eley T, Stevenson J (1999). Exploring the covariation between anxiety and depression symptoms: a genetic analysis of the effects of the age and sex. Journal of Child Psychiatry 40, 1273-1282.
16. Elovainio M, Keltikangas-Järvinen L, Pulkki-Ra?back L, Kivimäki M, Puttonen S, Viikari L, Räsänen L, Mansikkaniemi K, Viikari J, Raitakari OT (2006). Depressive symptoms and C-reactive protein: The Cardiovascular Risk in Young Finns Study. Psychological Medicine 36, 797-805. (Pubitemid 43744773)
17. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GDO, Rumley A, Marmot MG, Ferrie JE (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 39, 413-423.
18. Hoehn-Saric R, McLeod DR, Lee YB, Zimmerli WD (1991). Cortisol levels in generalized anxiety disorder. Psychiatry Research 38, 313-315.
19. Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71, 171-186.
20. Janicki Deverts D, Cohen S, Dilillo VG, Lewis CE, Kiefe C, Whooley M, Matthews KA (2010). Depressive symptoms, race, and circulating C-reactive protein: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosomatic Medicine 72, 734-741.
21. Kaufman J, Martin A, King R, Charney D (2001). Are child-, adolescent-, and adult-onset depression one and the same disorder ? Biological Psychiatry 49, 980-1001. (Pubitemid 32595458)
22. Kendler KS (1996). Major depression and generalised anxiety disorder. Same genes, (partly) different environments-revisited. British Journal of Psychiatry Supplement 30, 68-75.
23. Kendler KS, Gardner CO, Gatz M, Pedersen NL (2007). The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychological Medicine 37, 453-462.
24. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ (1995). The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Archives of General Psychiatry 52, 374-383.
25. Kessler RC, Chiu WT, Demler O, Walters EE (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archive of General Psychiatry 62, 617-627. (Pubitemid 40973437)
26. Kuzma JM, Black DW (2004). Integrating pharmacotherapy and psychotherapy in the management of anxiety disorders. Current Psychiatry Reports 6, 268-273. (Pubitemid 39173542)
27. MacKinnon D, Lockwood C, Hoffman J, West S, Sheets V (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7, 83-104.
28. Mantella RC, Butters MA, Amico JA, Mazumdar S, Rollman BL, Begley AE, Reynolds CF, Lenze EJ (2008). Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 33, 773-781.
29. Matthews KA, Schott LL, Bromberger JT, Cyranowski JM, Everson-Rose SA, Sowers M (2010). Are there bidirectional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behavior and Immunity 24, 96-101.
30. McDade TW, Burhop J, Dohnal J (2004). High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clinical Chemistry 50, 652-654. (Pubitemid 38297322)
31. McDade TW, Hawkley LC, Cacioppo JT (2006). Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago Health, Aging, and Social Relations Study. Psychosomatic Medicine 68, 376-381. (Pubitemid 44297667)
32. McDade TW, Leonard WR, Burhop J, Reyes-Garc?́a V, Vadez V, Huanca T, Godoy RA (2005). Predictors of C-reactive protein in Tsimane' 2 to 15 year-olds in lowland Bolivia. American Journal of Physical Anthropology 128, 906-913. (Pubitemid 41746207)
33. McDade W, Stallings JF, Worthman CM (1997). Psychosocial stress and cell-mediated immune function: validation of a blood spot method for Epstein-Barr virus antibodies. American Journal of Physical Anthropology 24 (Suppl.), 164-165.
34. Mei JV, Alexander JR, Adam BW, Hannon WH (2001). Use of filter paper for the collection and analysis of human whole blood specimens. Journal of Nutrition 131, 1631S-1636S. (Pubitemid 32422996)
35. Middeldorp C, Birley A, Cath D, Gillespie N, Willemsen G, Statham D, De Geus E, Andrews J, Van Dyck R, Beem A, Sullivan P, Martin N, Boomsma D (2005). Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Research and Human Genetics 8, 609-615. (Pubitemid 41746446)
36. Moffitt TE, Caspi A, Harrington H, Milne BJ, Melchior M, Goldberg D, Poulton R (2007a). Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. Psychological Medicine 37, 441-452.
37. Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R (2007b). Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Archives of General Psychiatry 64, 651-660. (Pubitemid 46878666)
38. National Center for Health Statistics (1988). Child Health Supplement. In: Current Estimates from the National Health Interview Survey (ed. P. Adams and A. Hardy), Hyattsville, MD.
39. O'Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin M-T, O'Farrelly C, Malone KM (2010). Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain, Behavior and Immunity 24, 1074-1077.
40. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002). Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109, 45-60. (Pubitemid 34049426)
41. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith Jr., SC, Taubert K, Tracy RP, Vinicor F (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511. (Pubitemid 36158056)
42. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C (2006). Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study. Atherosclerosis 185, 320-326.
43. Pradhan AD, Manson JE, Rifai M, Buring JE, Ridker PM (2002). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286, 327-334.
44. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31. (Pubitemid 43083561)
45. Ridker PM, Buring JE, Cook NR, Rifai N (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107, 391-397.
46. Schweizer EE, Swenson CM, Winokur A, Rickels K, Maislin G (1986). The dexamethasone suppression test in generalised anxiety disorder. British Journal of Psychiatry 149, 320-322. (Pubitemid 16021003)
47. Shah T, Casas JP, Cooper JA, Tzoulaki I, Sofat R, McCormack V, Smeeth L, Deanfield JE, Lowe GD, Rumley A, Fowkes FGR, Humphries SE, Hingorani AD (2009). Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. International Journal of Epidemiology 38, 217-231.
48. Shanahan L, Copeland W, Costello EJ, Angold A (2008). Specificity of putative psychosocial risk factors for psychiatric disorders in children and adolescents. Journal of Child Psychology & Psychiatry 49, 34-42.
49. Sobel ME (1982). Asymptomic confidence intervals for indirect effects in structural equation models. Sociological Methodology 13, 290-312.
50. Stewart JC, Rand KL, Muldoon MF, Kamarck TW (2009). A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior and Immunity 23, 936-944.
51. Tamakoshi K, Yatsya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H (2003). The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. International Journal of Obesity and Related Metabolic Disorders 27, 443-449. (Pubitemid 36520842)
52. Thapar A, McGuffin P (1997). Anxiety and depressive symptoms in childhood: A genetic study of comorbidity. Journal of Child Psychology and Psychiatry 38, 651-656. (Pubitemid 27437731)
53. The Emerging Risk Factors Collaboration (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant metaanalysis. Lancet 375, 132-140.
54. Tiller JWG, Biddle N, Maguire KP, Davies BM (1988). The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biological Psychiatry 23, 261-270. (Pubitemid 18047595)
55. Toker S, Shirom A, Shapira I, Berliner S, Melamed S (2005). The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. Journal of Occupational Health Psychology 10, 344-362. (Pubitemid 41636234)
56. Watson D (2005). Rethinking the mood and anxiety disorders: A quantitative hierarchical model for DSM-V. Journal of Abnormal Psychology 114, 522-536. (Pubitemid 41746989)
57. Williams SR, McDade TW (2009). The use of dried blood spot sampling in the National Social Life, Health, and Aging Project. Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64B, i131-i136.
58. Woodward M, Rumley A, Lowe GDO, Tunstall-Pedoe H (2003). C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 122, 135-141. (Pubitemid 36819348)
59. Worthman CM, Stallings JF (1997). Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. American Journal of Physical Anthropology 103, 1-21. (Pubitemid 27431114)